Mariana Bonacossa Sant’aNna
Research Subjects
Mariana Bonacossa Sant’aNna has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Lucas Bonacossa Sant’anna
Fundação Técnico-Educacional Souza Marques (FTESM), Rio de Janeiro, RJ - Brasil
6 shared publications - Fernando Mendes Sant'ANna
Hospital Santa Izabel - Cardiologia, Cabo Frio, RJ - Brasil
5 shared publications - Aloysio Guimarães da Fonseca
Hospital Universitário Pedro Ernesto
2 shared publications - Eduardo Xavier Hias Pozzobon
Hospital Universitário Pedro Ernesto
2 shared publications - Igor Martins Moreira
Hospital Universitário Pedro Ernesto
2 shared publications - Sérgio Lívio Menezes Couceiro
Universidade Federal Fluminense - Cardiologia, Cabo Frio, RJ - Brasil
2 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Revista Brasileira de Neurologia in Revista Brasileira de Neurologia
- Vol. 62 (3)
A case-based narrative review of the diagnostic approach to central nervous system demyelinating disorders
Central nervous system demyelinating disorders (CNS-DD) can cause abrupt, disabling, yet potentially reversible neurologic deficits; rapid recognition is essential because acute immunotherapy is time-sensitive. This narrative review, anchored in a three-patient case series, outlines a practical diagnostic workflow to differentiate the main inflammatory demyelinating syndromes. We describe: (1) multiple sclerosis in a 23-year-old man with optic neuritis, typical brain MRI lesions, and cerebrospinal fluid oligoclonal bands fulfilling McDonald criteria; (2) aquaporin-4–IgG–positive neuromyelitis optica spectrum disorder in a 24-year-old woman with longitudinally extensive myelitis, optic symptoms, and area postrema syndrome; and (3) MOG antibody-associated disease in a 23-year-old postpartum woman with ADEM-like encephalopathy and strongly positive serum MOG-IgG. Across entities, lesion topography on brain/spine MRI, CSF profile, and serum antibody testing (AQP4-IgG, MOG-IgG) are pivotal to exclude mimics and guide early treatment.
- 1 October 2026
- Published by Revista Brasileira de Neurologia in Revista Brasileira de Neurologia
- Vol. 62 (3)
Open AccessA case-based narrative review of the diagnostic approach to central nervous system demyelinating disorders
Central nervous system demyelinating disorders (CNS-DD) can cause abrupt, disabling, yet potentially reversible neurologic deficits; rapid recognition is essential because acute immunotherapy is time-sensitive. This narrative review, anchored in a three-patient case series, outlines a practical diagnostic workflow to differentiate the main inflammatory demyelinating syndromes. We describe: (1) multiple sclerosis in a 23-year-old man with optic neuritis, typical brain MRI lesions, and cerebrospinal fluid oligoclonal bands fulfilling McDonald criteria; (2) aquaporin-4–IgG–positive neuromyelitis optica spectrum disorder in a 24-year-old woman with longitudinally extensive myelitis, optic symptoms, and area postrema syndrome; and (3) MOG antibody-associated disease in a 23-year-old postpartum woman with ADEM-like encephalopathy and strongly positive serum MOG-IgG. Across entities, lesion topography on brain/spine MRI, CSF profile, and serum antibody testing (AQP4-IgG, MOG-IgG) are pivotal to exclude mimics and guide early treatment.
- Open Access
- 3 July 2026
- Published by Revista Brasileira de Neurologia in Revista Brasileira de Neurologia
- Vol. 62 (2)
Longitudinally extensive transverse myelitis with encephalopathy following acute dengue infection
Dengue is a common arboviral infection in tropical/subtropical regions; neurologic complications occur in ~5% of cases, usually as encephalopathy from systemic illness (1). Viral neurotropism and immune-mediated injury are rare and mimic infectious/inflammatory etiologies (2,3). Although corticosteroids are not routinely recommended, case reports describe high-dose steroids usage with favorable outcomes (4,5). A previously healthy 25-year-old man in Brazil developed fever and retro-orbital headache followed by disorientation, hallucinations, abdominal pain, urinary retention, and rapidly progressive areflexic paraparesis. CSF showed lymphocytic pleocytosis (140 cells/µL); infectious and autoimmune/demyelinating tests were negative. MRI revealed longitudinally extensive intramedullary hyperintensity from upper cervical cord to conus with leptomeningeal enhancement. Dengue IgM with IgM/IgG seroconversion confirmed acute infection. IV methylprednisolone (1 g/day) improved symptoms within 72h; he walked by day 5 and fully recovered within 1 year. In endemic settings, neurodengue is a possibility when alternatives are excluded. Once infection is ruled out, immunotherapy should be considered.
- 3 July 2026
- Published by Revista Brasileira de Neurologia in Revista Brasileira de Neurologia
- Vol. 62 (2)
Open AccessLongitudinally extensive transverse myelitis with encephalopathy following acute dengue infection
Dengue is a common arboviral infection in tropical/subtropical regions; neurologic complications occur in ~5% of cases, usually as encephalopathy from systemic illness (1). Viral neurotropism and immune-mediated injury are rare and mimic infectious/inflammatory etiologies (2,3). Although corticosteroids are not routinely recommended, case reports describe high-dose steroids usage with favorable outcomes (4,5). A previously healthy 25-year-old man in Brazil developed fever and retro-orbital headache followed by disorientation, hallucinations, abdominal pain, urinary retention, and rapidly progressive areflexic paraparesis. CSF showed lymphocytic pleocytosis (140 cells/µL); infectious and autoimmune/demyelinating tests were negative. MRI revealed longitudinally extensive intramedullary hyperintensity from upper cervical cord to conus with leptomeningeal enhancement. Dengue IgM with IgM/IgG seroconversion confirmed acute infection. IV methylprednisolone (1 g/day) improved symptoms within 72h; he walked by day 5 and fully recovered within 1 year. In endemic settings, neurodengue is a possibility when alternatives are excluded. Once infection is ruled out, immunotherapy should be considered.
- Open Access
- 21 June 2026
- Published by Instituto Nacional de Cardiologia - Brazil in OnScience
- Vol. 4 (1) , e0073
Infective endocarditis due to cardiac pacemaker infection
Introduction: Infective endocarditis (IE) related to cardiac implantable electronic devices (CIED) is rare but potentially fatal, and may compromise the generator, leads, or cardiac valves. Most cases occur in multimorbid patients and are caused by Staphylococcus aureus or S. epidermidis. Case report: An elderly patient with a dual-chamber pacemaker implanted four years earlier was admitted with sepsis, fever, and acute kidney injury. On examination, exposure of the generator unit with purulent discharge was noted. Echocardiography showed vegetations on the ventricular lead and the right atrial wall, and blood cultures were positive for S. aureus. Computed tomography revealed multiple cavitary nodules compatible with septic emboli. Device extraction was performed, followed by pathogen-directed antibiotic therapy for four weeks, with favorable progression and hospital discharge without sequelae. Conclusion: CIED-related IE requires rapid diagnosis and aggressive management. Microbiological confirmation, early detection of complications, and device removal combined with appropriate antibiotics were decisive for the favorable outcome.
- 21 June 2026
- Published by Instituto Nacional de Cardiologia - Brazil in OnScience
- Vol. 4 (1) , e0073
Open AccessInfective endocarditis due to cardiac pacemaker infection
Introduction: Infective endocarditis (IE) related to cardiac implantable electronic devices (CIED) is rare but potentially fatal, and may compromise the generator, leads, or cardiac valves. Most cases occur in multimorbid patients and are caused by Staphylococcus aureus or S. epidermidis. Case report: An elderly patient with a dual-chamber pacemaker implanted four years earlier was admitted with sepsis, fever, and acute kidney injury. On examination, exposure of the generator unit with purulent discharge was noted. Echocardiography showed vegetations on the ventricular lead and the right atrial wall, and blood cultures were positive for S. aureus. Computed tomography revealed multiple cavitary nodules compatible with septic emboli. Device extraction was performed, followed by pathogen-directed antibiotic therapy for four weeks, with favorable progression and hospital discharge without sequelae. Conclusion: CIED-related IE requires rapid diagnosis and aggressive management. Microbiological confirmation, early detection of complications, and device removal combined with appropriate antibiotics were decisive for the favorable outcome.
- Open Access
- 19 June 2023
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 120 (6) , e20230331
Melhorando as Metanálises
A metanálise (MA) de Meng-jin et al., publicada nesta edição da revista, traz informações importantes sobre o tratamento invasivo de pacientes idosos (≥ 75 anos) com infarto agudo do miocárdio sem supradesnivelamento do segmento ST (IAMSSST) versus tratamento conservador. Mesmo ciente dos benefícios da revascularização precoce em pacientes idosos e jovens, no primeiro grupo, sabe-se que a preocupação com os riscos de complicações em procedimentos invasivos reduz o número de intervenções nesse grupo. Por outro lado, com o rápido crescimento
- 19 June 2023
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 120 (6) , e20230331
Open AccessMelhorando as Metanálises
A metanálise (MA) de Meng-jin et al., publicada nesta edição da revista, traz informações importantes sobre o tratamento invasivo de pacientes idosos (≥ 75 anos) com infarto agudo do miocárdio sem supradesnivelamento do segmento ST (IAMSSST) versus tratamento conservador. Mesmo ciente dos benefícios da revascularização precoce em pacientes idosos e jovens, no primeiro grupo, sabe-se que a preocupação com os riscos de complicações em procedimentos invasivos reduz o número de intervenções nesse grupo. Por outro lado, com o rápido crescimento
- Open Access
- 2 May 2023
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 120 (5) , e20220581
Neuromodulação Vagal Auricular e sua Aplicabilidade em Pacientes com Insuficiência Cardíaca e Fração de Ejeção Reduzida
Resumo Fundamento O desequilíbrio do sistema nervoso autônomo (SNA) na insuficiência cardíaca (IC) cria um ciclo vicioso, o excesso de atividade simpática e a diminuição da atividade vagal contribuindo para a piora da IC. A estimulação elétrica transcutânea de baixa intensidade do ramo auricular do nervo vago (taVNS) é bem tolerada e abre novas possibilidades terapêuticas. Objetivos Gerar hipótese da aplicabilidade e benefício da taVNS na IC através da comparação intergrupos de parâmetros ecocardiográficos, teste de caminhada de 6 min, [...] Resumo Fundamento O desequilíbrio do sistema nervoso autônomo (SNA) na insuficiência cardíaca (IC) cria um ciclo vicioso, o excesso de atividade simpática e a diminuição da atividade vagal contribuindo para a piora da IC. A estimulação elétrica transcutânea de baixa intensidade do ramo auricular do nervo vago (taVNS) é bem tolerada e abre novas possibilidades terapêuticas. Objetivos Gerar hipótese da aplicabilidade e benefício da taVNS na IC através da comparação intergrupos de parâmetros ecocardiográficos, teste de caminhada de 6 min,
- 2 May 2023
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 120 (5) , e20220581
Open AccessNeuromodulação Vagal Auricular e sua Aplicabilidade em Pacientes com Insuficiência Cardíaca e Fração de Ejeção Reduzida
Resumo Fundamento O desequilíbrio do sistema nervoso autônomo (SNA) na insuficiência cardíaca (IC) cria um ciclo vicioso, o excesso de atividade simpática e a diminuição da atividade vagal contribuindo para a piora da IC. A estimulação elétrica transcutânea de baixa intensidade do ramo auricular do nervo vago (taVNS) é bem tolerada e abre novas possibilidades terapêuticas. Objetivos Gerar hipótese da aplicabilidade e benefício da taVNS na IC através da comparação intergrupos de parâmetros ecocardiográficos, teste de caminhada de 6 min, [...] Resumo Fundamento O desequilíbrio do sistema nervoso autônomo (SNA) na insuficiência cardíaca (IC) cria um ciclo vicioso, o excesso de atividade simpática e a diminuição da atividade vagal contribuindo para a piora da IC. A estimulação elétrica transcutânea de baixa intensidade do ramo auricular do nervo vago (taVNS) é bem tolerada e abre novas possibilidades terapêuticas. Objetivos Gerar hipótese da aplicabilidade e benefício da taVNS na IC através da comparação intergrupos de parâmetros ecocardiográficos, teste de caminhada de 6 min,
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (6) , e20230345
Auricular vagus nerve stimulation: a new option to treat inflammation in COVID-19?
COVID-19 is an infectious disease caused by the new coronavirus (SARS-CoV-2), which invades alveolar epithelial cells through angiotensin-2 converting enzyme (ACE2) receptors1 1 Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.e8. https://doi.org/10.1016/j.cell.2020.02.052 https://doi.org/10.1016/j.cell.2020.02.0... ,2 2 Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. https://doi.org/10.1038/s41569-020-0360-5 https://doi.org/10.1038/s41569-020-0360-... . Infection is triggered by the binding of the spike protein (S) of SARS-CoV-1 or SARS-CoV-2 to ACE23 3 Costa IBSDS, Bittar CS, Rizk SI, Araújo Filho AE, Santos KAQ, Machado TIV, et al. The heart and COVID-19: what cardiologists need to know. Arq Bras Cardiol. 2020;114(5):805-16. https://doi.org/10.36660/abc.20200279 https://doi.org/10.36660/abc.20200279... and, through this binding, the virus enters the host cell, where ACE2 is later inactivated. As this enzyme is abundantly found in alveolar epithelial cells and in the myocardium, potentially serious damage can occur in the lungs and heart2 2 Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. https://doi.org/10.1038/s41569-020-0360-5 https://doi.org/10.1038/s41569-020-0360-... ,4 4 Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. COVID-19: a promising cure for the global panic. Sci Total Environ. 2020;725:138277. https://doi.org/10.1016/j.scitotenv.2020.138277 https://doi.org/10.1016/j.scitotenv.2020... .
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (6) , e20230345
Open AccessAuricular vagus nerve stimulation: a new option to treat inflammation in COVID-19?
COVID-19 is an infectious disease caused by the new coronavirus (SARS-CoV-2), which invades alveolar epithelial cells through angiotensin-2 converting enzyme (ACE2) receptors1 1 Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.e8. https://doi.org/10.1016/j.cell.2020.02.052 https://doi.org/10.1016/j.cell.2020.02.0... ,2 2 Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. https://doi.org/10.1038/s41569-020-0360-5 https://doi.org/10.1038/s41569-020-0360-... . Infection is triggered by the binding of the spike protein (S) of SARS-CoV-1 or SARS-CoV-2 to ACE23 3 Costa IBSDS, Bittar CS, Rizk SI, Araújo Filho AE, Santos KAQ, Machado TIV, et al. The heart and COVID-19: what cardiologists need to know. Arq Bras Cardiol. 2020;114(5):805-16. https://doi.org/10.36660/abc.20200279 https://doi.org/10.36660/abc.20200279... and, through this binding, the virus enters the host cell, where ACE2 is later inactivated. As this enzyme is abundantly found in alveolar epithelial cells and in the myocardium, potentially serious damage can occur in the lungs and heart2 2 Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60. https://doi.org/10.1038/s41569-020-0360-5 https://doi.org/10.1038/s41569-020-0360-... ,4 4 Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. COVID-19: a promising cure for the global panic. Sci Total Environ. 2020;725:138277. https://doi.org/10.1016/j.scitotenv.2020.138277 https://doi.org/10.1016/j.scitotenv.2020... .